Developing a national Real-World Evidence decision making framework
Developing a national Real-World Evidence decision making framework
批准号:
411907
负责人:
Chan Kelvin K
金额:
$0.73万
依托单位国家:
加拿大
项目类别:
Miscellaneous Programs
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-09-01 至 2020-09-01
中文摘要
背景资料:加拿大癌症药物价值的真实世界证据(CanREValue)合作是一个由研究人员,临床医生,决策者和其他致力于建立使用真实世界证据(RWE)的框架的泛加拿大团队
英文摘要
Background: The Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) collaboration is a pan-Canadian team of researchers, clinicians, decision-makers, and others committed to establishing a framework for the use of real-world evidence (RWE)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The 2023 Canadian Centre for Applied Research in Cancer Control (ARCC) Conference
-
批准号:480786
-
项目类别:Miscellaneous Programs
-
资助金额:$0.73万
-
财政年份:2023
-
负责人:Chan Kelvin K
-
依托单位:
Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada
-
批准号:367550
-
项目类别:Operating Grants
-
资助金额:$70.71万
-
财政年份:2017
-
负责人:Chan Kelvin K
-
依托单位:
A Multi-Province Approach to Real World Evidence Development for Cancer Drugs: A Case Study of Melanoma
-
批准号:358980
-
项目类别:Operating Grants
-
资助金额:$7.21万
-
财政年份:2016
-
负责人:Chan Kelvin K
-
依托单位:
Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada
-
批准号:360956
-
项目类别:Operating Grants
-
资助金额:$1.42万
-
财政年份:2016
-
负责人:Chan Kelvin K
-
依托单位: